Arrowhead Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Arrowhead Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Arrowhead Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Arrowhead Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $32M | 918k | 34.49 |
| 2025-06-30 | $25M | 1.6M | 15.80 |
| 2025-03-31 | $21M | 1.6M | 12.74 |
| 2024-12-31 | $25M | 1.3M | 18.80 |
| 2024-09-30 | $8.6M | 442k | 19.37 |
| 2024-06-30 | $9.1M | 348k | 25.99 |
| 2024-03-31 | $13M | 451k | 28.60 |
| 2023-12-31 | $16M | 509k | 30.60 |
| 2023-09-30 | $9.9M | 370k | 26.87 |
| 2023-06-30 | $12M | 331k | 35.69 |
| 2023-03-31 | $7.6M | 299k | 25.40 |
| 2022-12-31 | $13M | 308k | 40.56 |
| 2022-09-30 | $3.4M | 104k | 33.02 |
| 2022-06-30 | $3.2M | 91k | 35.21 |
| 2022-03-31 | $7.4M | 159k | 46.49 |
| 2021-12-31 | $10M | 155k | 66.30 |
| 2021-09-30 | $8.1M | 130k | 62.43 |
| 2021-06-30 | $6.0M | 72k | 82.85 |
| 2021-03-31 | $4.8M | 72k | 66.32 |
| 2020-12-31 | $887k | 12k | 76.76 |
| 2020-09-30 | $1.4M | 33k | 43.06 |
| 2020-06-30 | $337k | 7.8k | 43.18 |
| 2020-03-31 | $347k | 12k | 28.81 |
| 2019-12-31 | $13M | 208k | 63.42 |
| 2019-09-30 | $6.0M | 211k | 28.18 |
| 2019-06-30 | $3.0M | 114k | 26.49 |
| 2019-03-31 | $1.0M | 55k | 18.33 |
| 2018-12-31 | $3.5M | 279k | 12.42 |
| 2018-09-30 | $1.6M | 84k | 19.16 |
| 2018-06-30 | $451k | 33k | 13.61 |
| 2018-03-31 | $1.5M | 203k | 7.21 |
| 2017-12-31 | $70k | 23k | 3.12 |
| 2017-09-30 | $51k | 12k | 4.30 |
| 2017-06-30 | $9.5k | 5.7k | 1.68 |
| 2017-03-31 | $10k | 5.3k | 1.89 |
| 2016-12-31 | $23k | 15k | 1.57 |
| 2016-09-30 | $154k | 21k | 7.35 |
| 2016-06-30 | $43k | 8.6k | 5.00 |